Both Dr. McHutchison and Dr. Cheng will report to John Milligan, PhD, Gilead's President and Chief Executive Officer. Amgen, Inc. (NASDAQ: AMGN) Market Cap: 136.87B, current share price: $190.01 AMGN recently announced the final results of its modified Dutch auction tender offer, which expired at 12:00 Midnight, New York City time, at the end of Monday, March 5, 2018. Amgen has accepted for purchase 52,083,333 shares of its common stock, $0.0001 par value per share, at a price of $192 per share, for an aggregate cost of approximately $10 billion, excluding fees and expenses relating to the tender offer. These shares represent approximately 7.2 percent of the shares outstanding. The tender offer was oversubscribed and pursuant to the terms of the tender offer, shares will be accepted on a pro rata basis.